1-3 of 3
Matthew J. Ahearne
Close
Sort by
Journal Articles

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Clinical Trials & Observations
Rohan Shotton, Rachel Broadbent, Alia Alchawaf, Mohamed Bakri Mohamed, Adam Gibb, Nicolás Martinez-Calle, Christopher P. Fox, Mark Bishton, Alexandra Pender, Mary Gleeson, David Cunningham, Andrew Davies, Sina Yadollahi, Toby A. Eyre, Graham Collins, Faouzi Djebbari, Shireen Kassam, Paula Garland, Emily Watts, Wendy Osborne, William Townsend, Rachael Pocock, Matthew J. Ahearne, Fiona Miall, Xin Wang, Kim M. Linton
Journal: Blood Advances
Blood Adv (2024) 8 (4): 878–888.
https://doi.org/10.1182/bloodadvances.2023011305
Published: 2024
Includes: Supplemental data
Journal Articles

Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma

Barbara Ottolini, Nadia Nawaz, Christopher S. Trethewey, Sami Mamand, Rebecca L. Allchin, Richard Dillon, Paul A. Fields, Matthew J. Ahearne, Simon D. Wagner
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2392–2403.
https://doi.org/10.1182/bloodadvances.2019001075
Published: 2020
Includes: Supplemental data
Journal Articles

Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells

Sami Mamand, Matthew Carr, Rebecca L. Allchin, Matthew J. Ahearne, Simon D. Wagner
Journal: Blood Advances
Blood Adv (2019) 3 (5): 705–710.
https://doi.org/10.1182/bloodadvances.2018027821
Published: 2019
Includes: Supplemental data